Manual of lipid disorders : reducing the risk for coronary heart disease
著者
書誌事項
Manual of lipid disorders : reducing the risk for coronary heart disease
Lippincott Williams & Wilkins, 2002
3rd ed.
大学図書館所蔵 件 / 全2件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
The newly revised third edition of this practical manual offers up-to-date clinical guidelines for evaluating and treating lipid disorders and reducing the risk for coronary heart disease. The book reviews recent advances in the understanding of lipid metabolism and atherogenesis, examines clinical trial results with lipid-regulating drugs, and discusses appropriate dietary and lifestyle modifications. This edition includes the 2001 National Cholesterol Education Program clinical guidelines for assessment and management of lipid disorders in adults. Close attention is given to plasma lipid control and coronary heart disease risk reduction in patients with diabetes mellitus, overweight/obese individuals, women, elderly patients, and younger patients.
目次
I. Fundamentals of Lipid Metabolism 1. Plasma Lipoproteins: Structure, Nomenclature, and Occurrence 2. Intracellular Lipid Synthesis and Lipoprotein Assembly 3. Remodeling of Lipoproteins in the Plasma Compartment 4. Lipoprotein Catabolism and Its Regulation References II. Artherosclerosis 5. Atherosclerosis: Overview and Histologic Classification of Lesions 6. Evolution of Lesions 7. Lesion Regression and Stabilization References III. Risk Control 8. Observational Epidemiology and Risk Factors 9. Major Lipid-Regulating Drug Trials Assessing Clinical Events 10. National Cholestrol Education Program Clinicla Guidelines for Risk Control in Adults 11. Considerations in the Clinical Evaluation of Dyslipidemia IV. Therapeutic Interventions 12. Dietary Modification 13. Other Lifestyle Changes and Major Modifiable Risk Factors 14. Lipid-Regulating Drugs and Low-Density Lipoprotein Apheresis References V. Plasma Lipid Control and Coronary Heart Disease Risk Considerations in Population Subsets 15. Women 16. The Elderly and Youths 17. U.S Ethnic Minorities 18. Adults with Diabetes Mellitus and Patients with Concomitant Dyslipidemia and Hypertension References Index Chart 1: Lipid Conversions, with NCEP Initial Clinical Action Limits in Adults Chart 2: Cutpoints in Adult Clinical Practice Guideline
「Nielsen BookData」 より
